D. Clark

Indirect Method for Assessing the Penetration of Beta-Lactamase-Nonsusceptible Penicillins and Cephalosporins in Escherichia coli Strains

M. Richmond, S. Wotton, D. Clark, 1976, Antimicrobial Agents and Chemotherapy.

Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) as a target for anti-amoebic agents.

S. Stanley, D. Clark, A. Espinosa, 2004, The Journal of antimicrobial chemotherapy.

The Bifunctional Entamoeba histolytica Alcohol Dehydrogenase 2 (EhADH2) Protein Is Necessary for Amebic Growth and Survival and Requires an Intact C-terminal Domain for Both Alcohol Dehydrogenase and Acetaldehyde Dehydrogenase Activity*

S. Stanley, E. Li, Lynne R Foster, 2001, The Journal of Biological Chemistry.

Modified mutagen metabolism in Schistosoma hematobium-infested organisms.

M. Aardema, H. Blankespoor, J. Gentile, 1985, Archives of environmental health.

Complementation of an Escherichia coli adhE mutant by the Entamoeba histolytica EhADH2 gene provides a method for the identification of new antiamebic drugs.

S. Stanley, T. Yong, E. Li, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Permeability and susceptibility of Escherichia coli to beta-lactam compounds.

D. Clark, 1981, Antimicrobial agents and chemotherapy.